Collector
Giriş Yap
Wockhardt targets 50% of revenue from novel drugs within five years | Collector
Wockhardt targets 50% of revenue from novel drugs within five years

Wockhardt targets 50% of revenue from novel drugs within five years

Wockhardt expects novel drugs to contribute over half its revenue within five years as it expands a differentiated antibiotic portfolio built through decades of RD

Go to News Site